BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE Recalls

2 recalls found for BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE. Check if any of your products are affected.

HIGHFDA DRUG

Unichem Pharmaceuticals Recalls Bisoprolol Tablets Over Impurity Risk

Unichem Pharmaceuticals recalled Bisoprolol Fumarate and Hydrochlorothiazide tablets on January 21, 2026. The recall affects tablets that do not meet impurity specifications for N-Nitroso Bisoprolol. Consumers should stop using the product and contact their healthcare provider immediately.

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
cGMP Deviations:
Read more
HIGHFDA DRUG

Glenmark Pharmaceuticals Recalls Bisoprolol Tablets Due to Contamination

Glenmark Pharmaceuticals recalled over 11,000 bottles of Bisoprolol Fumarate and Hydrochlorothiazide Tablets on November 21, 2025. Testing revealed traces of ezetimibe, posing a health risk. Consumers should stop using the product immediately and contact their healthcare provider.

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
Cross Contamination
Read more

Brand Statistics

Total Recalls
2
Pages
1

Related Brands

Unichem Pharmaceuticals (USA), Inc.GLENMARK PHARMACEUTICALS INC., USA